Martijn D. de Kruif - Concepedia

Author

Martijn D. de Kruif

Also Known As

De Kruif, M., Frits H. M. van Osch, Kees Brinkman, M D de Kruif, M DEKRUIF, M. D. De Kruif, M. D. de Kruif, M. de Kruif, M.D de Kruif, M.D. DE KRUIF

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Zuyderland Medisch Centrum Maastricht University University of Amsterdam Amsterdam UMC Location University of Amsterdam Slotervaartziekenhuis

About

Martijn D. de Kruif is an author at Zuyderland Medisch Centrum specializing in medicine, vascular biology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	544
2	Public Health	3	3	147
3	Emergency Medicine	3	3	86
4	Health Sciences	2	2	67
5	Diabetes	1	1	45

Martijn D. de Kruif

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study Sofía Ramiro, Rémy L.M. Mostard, César Magro‐Checa, Annals of the Rheumatic Diseases	2020	231
Induction of IRAK-M Is Associated with Lipopolysaccharide Tolerance in a Human Endotoxemia Model Cornelis van ′t Veer, Petra S. van den Pangaart, Marieke A. D. van Zoelen, The Journal of Immunology Il-10 ExpressionLps ToleranceImmunologyCell DeathImmunotherapy	2007	172
The influence of corticosteroids on the release of novel biomarkers in human endotoxemia Martijn D. de Kruif, Lucienne C.J.M. Lemaire, Ida A. J. Giebelen, Intensive Care Medicine	2007	102
Prednisolone Dose-Dependently Influences Inflammation and Coagulation during Human Endotoxemia Martijn D. de Kruif, Lucienne C.J.M. Lemaire, Ida A. J. Giebelen, The Journal of Immunology	2007	102
In Vivo Lipopolysaccharide Exposure of Human Blood Leukocytes Induces Cross-Tolerance to Multiple TLR Ligands Alex F. de Vos, Jennie M. Pater, Petra S. van den Pangaart, The Journal of Immunology	2009	100
Effects on Coagulation and Fibrinolysis Induced by Influenza in Mice With a Reduced Capacity to Generate Activated Protein C and a Deficiency in Plasminogen Activator Inhibitor Type 1 Tymen Keller, Koen F. van der Sluijs, Martijn D. de Kruif, Circulation Research Viral PathogenesisImmunologyInflammationThrombosisFibrinolysis Induced	2006	90
Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department Martijn D. de Kruif, Maarten Limper, Herman Gerritsen, Critical Care Medicine	2010	79
Changing epidemiology of dengue haemorrhagic fever in Indonesia Tatty E. Setiati, Jiri F. P. Wagenaar, Martijn D. de Kruif, Dengue DiseaseInfectious Disease EpidemiologyVector-borne PathogenMalariaInternational Health	2006	69
The Hemostatic Balance in HIV-Infected Patients with and without Antiretroviral Therapy: Partial Restoration with Antiretroviral Therapy Eefje Jong, Susan Louw, Joost C.M. Meijers, AIDS Patient Care and STDs ThrombosisVenous ThrombosisHiv/aids CounsellingHuman RetrovirusHematology	2009	53
Differential Gene Expression Changes in Children with Severe Dengue Virus Infections Martijn D. de Kruif, Tatty E. Setiati, A. T. A. Mairuhu, PLoS neglected tropical diseases	2008	52

Page 1